William Baker

William Baker, MBA, is an accomplished professional in the pharmaceutical industry with extensive experience in clinical quality assurance and regulatory affairs. Currently serving as Executive Director of Clinical Quality Assurance at Neurocrine Biosciences since September 2021, William has previously held key positions such as Principal Consultant at Commonwealth Clinical Research Group and Director of GCP Quality Assurance at ACADIA Pharmaceuticals Inc. William's background includes roles in clinical operations, auditing, and regulatory affairs at organizations like Alexion Pharmaceuticals, Sunovion Pharmaceuticals, and Boehringer Ingelheim. With a solid educational foundation that includes an MBA in Management and Organization from the University of New Haven and a Bachelor of Science in Chemistry from Southern Connecticut State University, William brings a wealth of expertise and leadership to the field.